Join
Live feed
·
INSIDERFilingvia Quantisnow
Agios Pharmaceuticals Inc. logo

Director Backstrom Jay T. was granted 1,447 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AGIO· Agios Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.